SCRS Talks – Details, episodes & analysis

Michelle Ray, Director of Customer Success with Greenphire, explores the challenges that delayed payments pose to research site sustainability. Michelle highlights key issues like the burden of delayed payments on site operations and recruitment, the complexity of invoicing, and the role of technology in simplifying payment workflows. Learn how innovating payment systems can streamline financial processes, creating a more sustainable future for sites, patients, and sponsors alike.

Renuka Agarwal, CEO and co-founder of UpTrials, is revolutionizing site workforce challenges. Renuka shares the inspiration behind founding UpTrials, and how the platform is making a significant impact by matching research sites with skilled candidates. Learn how UpTrials is streamlining the hiring process, improving time-to-fill rates, and bringing much-needed innovation to clinical research hiring processes.

UpTrials is AI-driven software designed to help clinical research employers hire top talent quickly. The platform algorithmically matches employers with prescreened candidates who have clinical research experience, training, or transferable skills, covering roles from coordinators to site leadership. Employers can contact UpTrials at info@uptrials.com, and job seekers can sign up at app.uptrials.com.

Carlos Bussey, CEO of Accelerate Recruitment Services, dives deep into the groundbreaking innovations his company is bringing to the table and their role in the SCRS Global Impact Partner program. Hear the journey of this forward-thinking organization working to support clinical research sites and revolutionize patient recruitment.

In this episode of SCRS Talks, we spoke with Jane Myles, VP of Clinical Trial Innovation at Curebase, a new Global Impact Partner. Jane shares what research sites should know about decentralized trial technology and some initiatives Curebase is working on that will impact sites.

Join SCRS in welcoming Clinical ink to the Global Impact Partner (GIP) program! Syed Faridi, Senior Director of Business Development, and Lane Nichols, Executive Vice President, Head of Product, share why they decided to become a GIP and what they see for the future of their relationship with clinical research sites.

This Clinical Trials Day is especially meaningful to SCRS because it is the same day as SCRS' first-ever Diversity Site Solutions Summit.  To share a preview of some of the critical discussions that we'll cover at the Summit, we are joined by Lorena Kuri from Bristol Myers Squibb, Lloryn Hubbard from PPD, and Jaleeysa King from Greenphire. We'll highlight some of the industry's biggest wins and opportunities to improve diverse representation in trials.  Plus, they'll share how they plan to partner with sites to meet the industry's diverse enrollment goals.

Please join us in welcoming Aspen Insights to the SCRS Global Impact Partner program! Walter Storm, co-founder and CEO of Aspen Insights shares how his organization is listening to sites to understand their pain points and developing solutions to resolve them using data analytics. Listen to hear some initiatives Aspen Insights is working on to support site sustainability and streamlined trial enrollment through applied data science, artificial intelligence, and machine learning.

In this episode, SCRS is excited to showcase H1, one of SCRS' newest Global Impact Partners. We spoke with Adam Wyckoff, Director of Product Management, Clinical Trials, who shares why H1 believes listening to site voices is important and how they plan to work more closely with research sites in the future.  For more information about H1, please reach out to H1 at elizabeth.schwartz@h1.co.

SCRS is celebrating 10 years since our founder, Christine K. Pierre, officially formed the organization! We spoke with Clare Grace, Chief Patient Officer at one of SCRS' first Global Impact Partners, Parexel, to look back on why SCRS was created and how it has evolved through the years. We also explore current industry challenges SCRS is working to address, including how prioritizing site success impacts everyone in clinical research.

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge, who shares more insight into this new law and how it may affect enrollment of diverse communities in trials.